Key Organics is a UK-based chemistry contract research organization (CRO) providing discovery, research, and development services alongside its proprietary Bionet library of complex research intermediates and screening compounds.
Key Organics is a UK-based contract research organization (CRO) founded in 1986 that provides specialized chemistry services to the global life sciences, pharmaceutical, agrochemical, and biotechnology sectors. The company integrates its research and development capabilities—including custom synthesis, process development, and scale-up—with Bionet, a proprietary collection of over 330,000 research intermediates, fragments, and screening compounds. By combining these discovery and manufacturing offerings, the company supports projects from hit identification and lead optimization through to pre-clinical development. Their expertise spans multi-step synthesis, heterocyclic chemistry, and the creation of stable-labeled compounds, supported by in-house analytical testing and quality accreditation.
These services enable pharmaceutical and biotechnology partners to accelerate drug discovery timelines and overcome complex synthetic challenges. Key Organics serves as a vital partner for companies seeking reliable chemical procurement and bespoke chemical solutions, often working on projects that require strict adherence to purity specifications and rapid turnaround. Following a management buyout in 2025, the company continues to operate as an independent entity from its headquarters in Camelford, Cornwall, maintaining a focus on delivering agile, high-quality chemical services and innovative compound products to an international customer base.